By
Drug Target Review2023-09-01T10:00:39
Researchers have shown insights into the omicron variants of the SARS-CoV-2 virus, which have rapidly disseminated globally in the past year.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-22T07:38:00Z
Contributor Dr Helen Bright, By Drug Target Review
2023-03-07T10:55:58
Sponsored by Agilent
2026-05-22T07:38:00
Contributor Dr Helen Bright, By Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud